EVOFEM BIOSCIENCES, INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
EVOFEM BIOSCIENCES, INC. (EVFM) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $30.75 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2019-11-07
- EVOFEM BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2019-03-31 was -$1.16M, a 129.79% decline year-over-year.
- EVOFEM BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2018-03-31 was $3.90M.
- EVOFEM BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2017-03-31 was -$6.40M.
- EVOFEM BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2018 was $60.00K.
- EVOFEM BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2017 was -$9.79M.
- EVOFEM BIOSCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2015 was -$38.00M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-09-30 | $30.75M 10-Q · filed 2019-11-07 | |||||
| 2019-06-30 | $49.32M 10-Q · filed 2019-08-06 | |||||
| 2019-03-31 | -$1.16M 10-Q · filed 2019-05-07 | |||||
| 2018-12-31 | $60.00K 10-K · filed 2019-03-01 | |||||
| 2018-09-30 | $10.82M 10-Q · filed 2019-11-07 | |||||
| 2018-06-30 | $21.64M 10-Q · filed 2019-08-06 | |||||
| 2018-03-31 | $3.90M 10-Q · filed 2019-05-07 | |||||
| 2017-12-31 | -$9.79M 10-K · filed 2019-03-01 | -$8.17M 10-K · filed 2018-02-26 | ||||
| 2017-09-30 | -$7.32M 10-Q · filed 2018-11-07 | -$5.83M 10-Q · filed 2017-11-08 | ||||
| 2017-06-30 | -$9.94M 10-Q · filed 2018-08-02 | |||||
| 2017-03-31 | -$6.40M 10-Q · filed 2018-05-14 | |||||
| 2016-12-31 | -$5.63M 8-K/A · filed 2018-04-06 | -$26.27M 10-K · filed 2018-02-26 | ||||
| 2016-09-30 | -$23.38M 10-Q · filed 2017-11-08 | |||||
| 2015-12-31 | -$38.00M 10-K · filed 2018-02-26 |